Clinical Trials Browser

Breast Neoplasms, Triple Negative Breast Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Adenocarcinoma Of Esophagus

Rectal Neoplasms

Somatostatinoma, Carcinoma, Neuroendocrine

Adenoma, Islet Cell

Pancreatic Neoplasms

Stomach Neoplasms

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Esophageal Neoplasms

Neuroectodermal Tumors, Primitive

Pancreatic Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Bile Duct Neoplasms, Gallbladder Neoplasms

Breast Neoplasms

Bile Duct Neoplasms, Gallbladder Neoplasms

Uterine Cervical Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms

Pancreatic Neoplasms

Uterine Cervical Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Astrocytoma, Central Nervous System Neoplasms

Gastro Oesophageal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms

Breast Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Neoplasms, Rectal Neoplasms

Clinical Trials

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

NEO-RT

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

INNOVATION

Lithium

TOPGEAR

METEORA-II

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

InterAACT

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

CONTROL NETS

MASTERPLAN

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Stop&Go

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

PETACC-6

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

ELECT

S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum

Preoperative Chemoradiation With Capecitabine and Cetuximab